Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome

Summary

The primary objective of this study is to compare the effect of rosuvastatin 10mg with atorvastatin 10mg in the percentage reduction of LDL-C in Subjects with metabolic syndrome after 6 weeks of treatment.

Timeline

Start

2005-08

Primary completion

—

Completion

2007-01

Drugs

Indications